A systematic evaluation of human expert agreement on optical coherence tomography biomarkers using multiple devices
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
https://www.nature.com/articles/s41433-022-02376-w.pdf
Reference34 articles.
1. Toth CA, Decroos FC, Ying GS, Stinnett SS, Heydary CS, Burns R, et al. Identification of Fluid on Optical Coherence Tomography by Treating Ophthalmologists Versus a Reading Center in the Comparison of Age-Related Macular Degeneration Treatments Trials. Retina. 2015;35:1303–14.
2. DeCroos FC, Toth CA, Stinnett SS, Heydary CS, Burns R, Jaffe GJ, et al. Optical coherence tomography grading reproducibility during the Comparison of Age-related Macular Degeneration Treatments Trials. Ophthalmology. 2012;119:2549–57.
3. Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118:615–25.
4. Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119:789–801.
5. Guymer RH, Markey CM, McAllister IL, Gillies MC, Hunyor AP, Arnold JJ, et al. Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results. Ophthalmology. 2019;126:723–34.
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Clinically significant macular edema in an underserved population: Association with demographic factors and hemoglobin A1c;Optometry and Vision Science;2024-01
2. Clinical Characteristics, Treatment Modalities, and Their Association with Long-term Visual Outcomes in Uveal Effusion Syndrome;Retina;2023-12-06
3. Automated System for Analysis of OCT Retina Images Development and Testing;Doklady Mathematics;2023-12
4. Impact of A-Scan Rate on Image Quality and Acquisition Time in OCT;Current Eye Research;2023-07-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3